UK Shareholder Meetings Calendar - Next 7 Days Read More
IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus Read More
IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall Read More
IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement Read More
ValiRx Delays Annual Results Amid Covid-19 Pandemic Read More
UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million Read More
UK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App Read More
UK EXECUTIVE CHANGE SUMMARY: ValiRx Appoints Biotaspheric CEO As Chair Read More
UK EXECUTIVE CHANGE SUMMARY: Connect Picks Ex-Synthomer CFO As Chair Read More
REPEAT: ValiRx Completes GBP1.2 Million Placing For Trial Close-Out Read More
ValiRx Competes GBP1.2 Million Placing To Fund VAL201 Trial Close-Out Read More
UK EXECUTIVE CHANGE SUMMARY: Immedia Picks COO Penney As Interim CEO Read More
ValiRx Signs Drug Transfer Agreement With Japanese Pharma Firm Read More
UK WINNERS & LOSERS SUMMARY: RBS Rises Despite Profit Sinking Read More
ValiRx Confirms JV Talks For Non-Core Intellectual Property Read More
UK EXECUTIVE CHANGE SUMMARY: Harvest Minerals CFO Leaves To Save Cost Read More
ValiRx Raises GBP200,000 To Improve "Extremely Weak" Capital Position Read More
ValiRx "Critically Short" Of Working Capital, In Funding Discussions Read More
ValiRx Still Faces Going Out Of Business; Proposes New Share Plan Read More
